减味连梅汤对DSS + LPS诱导的脓毒症小鼠的保护作用
Protective Effect of Jianwei Lianmei Decoction on DSS and LPS-Induced Septic Mice
DOI: 10.12677/acm.2026.1641363, PDF,    科研立项经费支持
作者: 李昱辰, 毛胜敏, 范嘉瑞, 白群华, 李迎丽*:重庆医科大学公共卫生学院,重庆;唐 勇:重庆市中医骨科医院门诊部,重庆
关键词: 减味连梅汤脓毒症LPS肠屏障炎症Jianwei Lianmei Decoction Sepsis LPS Intestinal Barrier Inflammation
摘要: 目的:探究连梅汤中的乌梅与黄连配伍(W + H)的减味连梅汤对脓毒症模型小鼠的保护效应。方法:C57BL/6J雄性小鼠经随机化处理后分为3组(n = 6):CON组、DSS + LPS模型组与W + H治疗组。模型组与W + H治疗组通过腹腔注射LPS (5 mg/kg)联用DSS建立肠损伤相关脓毒症模型。治疗组预先进行21天的减味连梅汤灌胃干预。随后,实验终点评估小鼠一般状态及肠、肝器官损伤状态。利用HE染色评估肠、肝形态学病变,并借助RT-qPCR分析结肠紧密连接蛋白(ZO-1)及肠、肝组织中关键炎性介质(IL-1β, IL-8, IL-17, TNF-α)的表达差异。结果:相比对照组,模型组表现出明显的体重减失及粪便性状异常(P < 0.001),以及肠、肝器官损伤。减味连梅汤干预显著逆转了上述表型,不仅上调了结肠ZO-1的表达(P < 0.05),还下调了肠道与肝脏内的促炎因子水平,并有效减轻了组织病理损害。结论:减味连梅汤对脓毒症引起的结肠屏障功能障碍具有修复作用,并能缓解结肠与肝脏的协同损伤。
Abstract: Objective: To investigate the protective effects of the flavor-reduced Lianmei Decoction combined with Wumei and Coptis (W + H) on septic model mice. Methods: Male C57BL/6J mice were randomly allocated into three experimental cohorts: the control (CON) group, the DSS + LPS-induced model group, and the W + H intervention group. The model group and W + H treatment group were subjected to intraperitoneal injection of LPS (5 mg/kg) combined with DSS to induce intestinal injury-related sepsis. The treatment group received a 21-day pre-treatment of flavor-reduced Lianmei Decoction via gavage. Following the intervention, general conditions of the mice and damage to intestinal and hepatic organs were assessed. HE staining was used to evaluate morphological lesions in the intestine and liver, and RT-qPCR was applied to analyze differences in the expression of colonic tight junction protein (ZO-1) and key inflammatory mediators (IL-1β, IL-8, IL-17, TNF-α) in intestinal and hepatic tissues. Results: Compared to the control group, the model group exhibited significant weight loss and abnormal fecal characteristics (P < 0.0001), as well as intestinal and hepatic organ damage. Intervention with flavor-reduced Lianmei Decoction significantly reversed these phenotypes, upregulated colonic ZO-1 expression (P < 0.05), downregulated pro-inflammatory factors in the intestine and liver, and effectively alleviated histopathological damage. Conclusion: Flavor-reduced Lianmei Decoction has a reparative effect on colonic barrier dysfunction induced by sepsis and can mitigate synergistic damage to the colon and liver.
文章引用:李昱辰, 唐勇, 毛胜敏, 范嘉瑞, 白群华, 李迎丽. 减味连梅汤对DSS + LPS诱导的脓毒症小鼠的保护作用[J]. 临床医学进展, 2026, 16(4): 1307-1315. https://doi.org/10.12677/acm.2026.1641363

参考文献

[1] Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
[2] Gavelli, F., Castello, L.M. and Avanzi, G.C. (2021) Management of Sepsis and Septic Shock in the Emergency Department. Internal and Emergency Medicine, 16, 1649-1661. [Google Scholar] [CrossRef] [PubMed]
[3] Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analysis for the Global Burden of Disease Study. The Lancet, 395, 200-211. [Google Scholar] [CrossRef] [PubMed]
[4] Seymour, C.W., Kennedy, J.N., Wang, S., Chang, C.H., Elliott, C.F., Xu, Z., et al. (2019) Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA, 321, 2003-2017. [Google Scholar] [CrossRef] [PubMed]
[5] Gyawali, B., Ramakrishna, K. and Dhamoon, A.S. (2019) Sepsis: The Evolution in Definition, Pathophysiology, and Management. SAGE Open Medicine, 7. [Google Scholar] [CrossRef] [PubMed]
[6] Arina, P. and Singer, M. (2021) Pathophysiology of Sepsis. Current Opinion in Anaesthesiology, 34, 77-84. [Google Scholar] [CrossRef] [PubMed]
[7] 刘柱, 王佳巍, 严静, 等. 中医药调控PI3K/Akt通路干预脓毒症的研究进展[J]. 中国实验方剂学杂志, 2025, 31(2): 314-322.
[8] 薛燕红, 杨秀芬. 脓毒症急性肺损伤的发病机制及治疗进展[J]. 河北医科大学学报, 2024, 45(4): 406-412.
[9] Clements, T.W., Tolonen, M., Ball, C.G. and Kirkpatrick, A.W. (2021) Secondary Peritonitis and Intra-Abdominal Sepsis: An Increasingly Global Disease in Search of Better Systemic Therapies. Scandinavian Journal of Surgery, 110, 139-149. [Google Scholar] [CrossRef] [PubMed]
[10] Hu, P., Yuan, M., Guo, B., Lin, J., Yan, S., Huang, H., et al. (2024) Citric Acid Promotes Immune Function by Modulating the Intestinal Barrier. International Journal of Molecular Sciences, 25, Article No. 1239. [Google Scholar] [CrossRef] [PubMed]
[11] Liu, Z., Zhang, Z., Chen, X., Ma, P., Peng, Y. and Li, X. (2023) Citrate and Hydroxycinnamate Derivatives from Mume Fructus Protect LPS-Injured Intestinal Epithelial Cells by Regulating the FAK/PI3K/AKT Signaling Pathway. Journal of Ethnopharmacology, 301, Article ID: 115834. [Google Scholar] [CrossRef] [PubMed]
[12] Du, M., Liu, X., Ji, X., Wang, Y., Liu, X., Zhao, C., et al. (2025) Berberine Alleviates Enterotoxigenic Escherichia coli-Induced Intestinal Mucosal Barrier Function Damage in a Piglet Model by Modulation of the Intestinal Microbiome. Frontiers in Nutrition, 11, Article ID: 1494348. [Google Scholar] [CrossRef] [PubMed]
[13] Duda-Madej, A., Gagat, P., Wiśniewski, J., Viscardi, S. and Krzyżek, P. (2025) Impact of Isoquinoline Alkaloids on the Intestinal Barrier in a Colonic Model of Campylobacter Jejuni Infection. International Journal of Molecular Sciences, 26, Article No. 10634. [Google Scholar] [CrossRef
[14] 吴华顺, 彭嘉雯, 孙巧茹. 减味涤痰定痫汤联合利培酮治疗精神分裂症的临床观察[J]. 中国民间疗法, 2022, 30(11): 61-63.
[15] 诸婧, 张金华, 盛平卫, 等. 龙胆泻肝汤减味治疗急性期湿疹临床研究[J]. 中国实用医药, 2019, 14(27): 8-10.